Viertes Gesetz zur Änderung arzneimittelrechtlicher und anderer Vorschriften

This legislative procedure involves updates to the laws governing the production, distribution, and regulation of medicinal products in Germany. It aims to streamline pharmaceutical regulations and ensure the legal framework remains current with healthcare needs. The changes primarily affect pharmaceutical companies, healthcare providers, and regulatory authorities responsible for drug safety and market approval.